Stocks

Biogen: What’s the Story behind Old Buddy Rocking the Neighborhood?

 Stocks

Beyond new surge of meme stocks, one of the most widely discussed news of the past week came in the form of approval for Biogen’s (BIIB) Alzheimer's drug Aduhelm. The approval polarized both the scientific and stock trading community. The stock, which on the day of the approval at one point peaked at about 64% gain, ended the week up about 40%.

June 14, 2021

views 2293

Popular posts

Stocks

Apple February MoM iPhone Sales down 9% in U.S., 16% in China.

April 1, 2024

views 2970
Cryptocurrencies

Elon Musk's Tesla has Added a Dogcoin (DOGE) Payment Form to its Website. The Meme Coin Soars.

May 6, 2024

views 2964
Stocks

JPMorgan's Q1 Revenue Up by 9% to $41.93 Billion, but Guidance Disappointed

April 12, 2024

views 2883
Commodities

Global Grain Price Recoveries Appears Excessively Bullish vis-à-vis Inventories and Weather Factors

April 24, 2024

views 2866
Currencies

USD May Return to Strengthening on Disappointing Inflation Report

April 10, 2024

views 2817
show more

Tech summary box

top crypto

© 2024 DRT

Client Agreement AML Policy Refund and Withdrawal policy Privacy Policy

Trading financial instruments involves substantial risk and is not suitable for all investors. The information herein is not a recommendation to trade nor investment research or an offer to buy or sell any instrument. It does not take into account your particular investment objectives, financial situation or needs and does not create a binding obligation on any of the Dr Trade Company to enter into any transaction with you. You are advised to perform an independent investigation of any transaction to determine whether any transaction is suitable for you.